Navigation Links
CryoLife Provides Initial 2010 Financial Guidance
Date:12/1/2009

ATLANTA, Dec. 1 /PRNewswire-FirstCall/ -- CryoLife, Inc. ( CRY), an implantable biological medical device and cardiovascular tissue processing company, announced its initial financial guidance for 2010.

The Company expects total revenues for the full year of 2010 to be between $118.0 million and $123.0 million, which includes between $1.5 million and $2.5 million related to funding received from the Department of Defense in connection with the development of BioFoam. The Company expects tissue processing and BioGlue revenues to increase between mid-single and low-double digits on a percentage basis in 2010 compared to 2009, with HemoStase revenues increasing significantly more than that on a percentage basis.

The Company expects earnings per share of between $0.36 and $0.40 for 2010, which reflects several process improvements, expense control and cost cutting initiatives that the Company implemented during the fourth quarter of 2009, including a reduction in workforce that is expected to reduce costs and expenses in excess of $2 million in 2010. The reduction in workforce and attrition results in an approximate 10% decrease in number of employees since the beginning of 2009. The Company expects to record a charge of approximately $400,000 in the fourth quarter of 2009 in connection with these actions.

Webcast of Presentation at Piper Jaffray Annual Health Care Conference

The Company's presentation today at the Piper Jaffray 21st Annual Health Care Conference at The New York Palace Hotel on December 1, 2009 at 4:30 pm ET will be webcast. Steven G. Anderson, president and chief executive officer of CryoLife, Inc., is scheduled to present.

CryoLife's live presentation may be accessed through its Web site, www.cryolife.com, on the Investor Relations page. An archived copy of the presentation will be available for 30 days on th
'/>"/>

SOURCE CryoLife, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CryoLife to Present at 21st Annual Piper Jaffray Health Care Conference
2. CryoLife to Present at Upcoming Investor Conferences in New York
3. CryoLife Reports Record Quarterly Revenues of $28.2 Million
4. CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam(R)
5. CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic
6. CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads
7. Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal
8. Mersana Therapeutics Provides Clinical Update from Ongoing Phase 1 Study of XMT-1001 in Patients with Advanced Solid Tumors
9. Cyberonics Provides Update on Tax Position
10. New Database from ANSI, AAMI, ASTM International, and DIN Provides Centralized Source of Information for Medical Device Professionals
11. Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)...  Novartis Pharmaceuticals Corporation (NPC) has been named the top ... on the annual DiversityInc Top 50 Companies for Diversity listing. ... for Diversity on April 23 at an awards ceremony in ... second on the DiversityInc Top 10 Companies for Recruitment list ... Groups list. David Epstein , Division ...
(Date:4/24/2015)... , April 24, 2015  Lannett Company, Inc. (NYSE: ... and increased its five-year revolving credit facility to $120 ... accordion feature that will allow the company to increase ... $30.0 million, subject to securing additional commitments from existing ... the credit facility remains December 18, 2018.   ...
(Date:4/24/2015)... Spain , April 24, 2015  Elekta has ... Monaco® treatment planning system , enabling European clinics ... supports major treatment techniques including advanced 3D planning, IMRT, ... system. Monaco ... as well improved workflow efficiency. Advancements in 3D planning ...
Breaking Medicine Technology:Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 2Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 3Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 4Lannett Expands Revolving Credit Facility To $120 Million 2Elekta CE marks for Monaco v5.10 treatment planning system 2
... VALLEY FORGE, Pa., June 13, 2011 Saint-Gobain ... adding a variety of ergonomic features that improve ... and solution storage applications. These improvements are based ... laboratory and pharmaceutical environments. Manufactured from ...
... Today Divine Skin Inc. (DSKX), a developer of ... analgesic intended to compete over the counter with the ... to begin shipping upon final authorization by the Drug ... on underserved and niche categories, of course our pain ...
Cached Medicine Technology:New Bio-Simplex™ Polypropylene Carboys Feature Ergonomic Design, Versatile Closure Options 2New Bio-Simplex™ Polypropylene Carboys Feature Ergonomic Design, Versatile Closure Options 3Divine Skin Announces New Pain Reliever to Compete With Tylenol, Advil, Aspirin 2Divine Skin Announces New Pain Reliever to Compete With Tylenol, Advil, Aspirin 3
(Date:4/26/2015)... Italian public health researchers have released new data ... and other asbestos-related industries. Surviving Mesothelioma has just posted ... to read it now. , University researchers ... Medicine analyzed more than 15,000 cases of mesothelioma between ... asbestos cancer was most common. , “Asbestos cement ...
(Date:4/26/2015)... From March 18th, 2015 toward the ... Master™ Dahryn Trivedi, spent a month traveling in India ... institutions in the efforts of creating highly advanced, effective ... for human health care. , During their journey, ... institutions. All lab facilities are approved by the U.S. ...
(Date:4/26/2015)... In an article published last month in ... biomechanics occurring during the use of handheld electronic devices such ... that use of a tablet increases mechanical demand on neck ... more than when the neck is in a neutral position. ... pointing out the potential hazards of overuse of mobile technology ...
(Date:4/25/2015)... The National League for Nursing's ... endeavor to prepare nurses to provide high quality, culturally ... according to a new report by the John A. ... , The project began in 2007 as a ... direction of Elaine Tagliareni, EdD, RN, CNE, FAAN, professor ...
(Date:4/25/2015)... The Hon. Ellen Tauscher, Independent Chair ... following statement following the deadly earthquake in Nepal: , ... in the deaths of more than 1,000 people. ... Nepal, Bangladesh, India and other parts of South Asia. ... the people of Nepal and the families of the ...
Breaking Medicine News(10 mins):Health News:New Investigation Finds Mesothelioma “Clusters” Around Italian Cement Plants, According to Surviving Mesothelioma 2Health News:Trivedi Science™ Has Started Scientific Research to Create More Effective Pharmaceuticals and Nutraceuticals 2Health News:Trivedi Science™ Has Started Scientific Research to Create More Effective Pharmaceuticals and Nutraceuticals 3Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 2Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 3Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 4Health News:Hartford Foundation Report Details Success of NLN's Advancing Care Excellence for Seniors (ACE.S) Program 2Health News:Hartford Foundation Report Details Success of NLN's Advancing Care Excellence for Seniors (ACE.S) Program 3
... Feb. 7 PartnerRe Ltd.,(NYSE: PRE ) announced ... the period December 1, 2007 - February 29, 2008 ... Cumulative Redeemable Preferred Shares, and,$0.40625 per share on the ... will be payable on March 3, 2008, to,shareholders of ...
... NHS Choices ( http://www.nhs.uk ), the,online ,front door, ... information,resource, Health A-Z, aimed to help people find ... Based on NHS accredited information, the A-Z directory,( ... on a topic in seconds, providing them with ...
... that run on both conventional gasoline and stored ... gap until more sustainable technology is developed, according ... publication International Journal of Automotive Technology and Management, ... even slow development of more sustainable fuel-cell powered ...
... release was issued,today jointly by Schiffrin Barroway Topaz & ... DISTRICT COURT DISTRICT OF MARYLAND (NORTHERN DIVISION), ... LITIGATION Civil Action No. MJG 05-1224, SUMMARY ... ALL PERSONS AND ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED ...
... Comes With Software that Provides Hands-on Learning, ... a patient,s,medical records is essential to quality medical ... and death of a patient. Electronic Health,Record (EHR) ... make patient history readily available in those critical ...
... Environmental Health Groups Call for Immediate Moratorium on Bisphenol,A ... CHURCH, Va., Jan. 7 Dozens of state,and national ... for an immediate moratorium on the use of bisphenol ... containers, based on the results of a,new study that ...
Cached Medicine News:Health News:The trouble with hybrids 2Health News:Summary Notice of Proposed Settlement and Settlement Hearing in Re Martek Biosciences Corp., Securities Litigation 2Health News:McGraw-Hill Higher Education Publishes Text on Innovative Electronic Health Records System 2Health News:Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study 2Health News:Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study 3Health News:Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study 4
... Vitamin D kit is an enzymeimmunoassay for ... hydroxylated metabolites in serum or plasma. Calibrators, ... labelled 25-OH D. The diluted samples are ... with a highly specific sheep 25-OH D ...
... for the control of glucose metabolism. It ... of Langerhans as the precursor, proinsulin, which is ... are secreted in equimolar amounts into the portal ... of two polypeptide chains, the A-chain and B-chain ...
... is an integral part of the enzymatic ... II as well as the degradation of ... ACE is primarily located in endothelial cells. ... parameter for sarcoidosis and myocardial infarction but ...
... Retinol binding Proetin (RBP) is small (21kD) ... complex with pre-albumin in blood but loses ... been deliverd to the target cells. The ... the glomerulus and catabolized in the,renal tubules ...
Medicine Products: